FR2704147A1 - Cell-regenerating composition and its application in the medical, veterinary and agricultural fields - Google Patents

Cell-regenerating composition and its application in the medical, veterinary and agricultural fields Download PDF

Info

Publication number
FR2704147A1
FR2704147A1 FR9304920A FR9304920A FR2704147A1 FR 2704147 A1 FR2704147 A1 FR 2704147A1 FR 9304920 A FR9304920 A FR 9304920A FR 9304920 A FR9304920 A FR 9304920A FR 2704147 A1 FR2704147 A1 FR 2704147A1
Authority
FR
France
Prior art keywords
composition
application
cell
veterinary
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9304920A
Other languages
French (fr)
Other versions
FR2704147B1 (en
Inventor
Leguern Jacques
Jeanbourquin Herve
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JEAMBOURQUIN HERVE
JEANBOURQUIN HERVE
Original Assignee
JEAMBOURQUIN HERVE
JEANBOURQUIN HERVE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JEAMBOURQUIN HERVE, JEANBOURQUIN HERVE filed Critical JEAMBOURQUIN HERVE
Priority to FR9304920A priority Critical patent/FR2704147B1/en
Publication of FR2704147A1 publication Critical patent/FR2704147A1/en
Application granted granted Critical
Publication of FR2704147B1 publication Critical patent/FR2704147B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Abstract

The composition is defined as follows: - 40% Dimethyl sulphoxide - 20% Isotonic serum + trace elements - 40% Local anaesthetic. This composition is applied, in particular, in the medical field as an antitumour and tissue-regenerating active principle, as well as in the agricultural/veterinary field for improving performance in all animal species.

Description

La présente invention concerne une composition régénératrice des cellules et son application en milieu mé- dical vétérinaire et agricole. The present invention relates to a cell regenerative composition and its application in veterinary and agricultural medical environments.

La présente invention concerne un produit dont la faculté essentielle est la modification des propriétés membranaires des cellules. The present invention relates to a product whose essential faculty is the modification of the membrane properties of cells.

La formule chimique de la composition est la suivante:
- 40 % Diméthylsulfoxyde
- 20 % Sérum isotonique + oligo-éléments
- 40 % Anesthésique local
La composition agit en activant la perméabilité membranaire des cellules. La composition augmente l'assimilation de l'Oxygène par la cellule, ce dernier permet une activation des réactions biochimiques oxydo-réduc- tives, les déchets métaboliques issus de ces réactions (toxines) sont ensuite rapidement éliminés dans le milieu extra-cellulaire.The chemical formula of the composition is as follows:
- 40% Dimethyl sulfoxide
- 20% Isotonic serum + trace elements
- 40% Local anesthetic
The composition acts by activating the membrane permeability of the cells. The composition increases the assimilation of Oxygen by the cell, which allows activation of biochemical redox reactions, the metabolic waste from these reactions (toxins) is then quickly eliminated in the extra-cellular medium.

Après injection de ce produit, toutes les cellules imprégnées de cette composition vont être " activées ll car mieux oxygénées, le résultat sur l'organisme entier se ressent rapidement dans les performances de l'animal
Ce rejeunissement cellulaire s'observe sur les cellules en voie de dégénerescence ou en voie de cancérisation. Cette activation cellulaire agit également sur les cellules du système immunitaire qui reprennent un fonctionnement normal.After injection of this product, all the cells impregnated with this composition will be "activated" because better oxygenated, the result on the whole organism is quickly felt in the performance of the animal.
This cell rejuvenation is observed on cells in the process of degeneration or in the process of cancerization. This cellular activation also acts on the cells of the immune system which resume normal functioning.

Cette composition je également sur les propriétés de contact des cellules, et notamment, des cellules cancéreuses. Ces dernières ont en effet leur inhibition de contact pertubée ce qui leur permet de se développer anarchiquement et d'occuper ainsi un volume très impor tant (tumeur). This composition I also on the contact properties of cells, and in particular, cancer cells. The latter have their disturbed contact inhibition which allows them to grow anarchically and thus occupy a very large volume (tumor).

En prèsence de cette substance, ces cellules retrouvent leurs rapacités initiales de reconnaissance et d'inhibition et ne se développent donc plus sans limi te
Les avantages de cette composition sont nombreux, et notamment dans le secteur agricole, les élevages de toutes espèces animales peuvent en bénéficier en vue d'améliorer leurs performances: productivité, fertilité, natalité, etc., tout en améliorant également la longévité des animaux. In the presence of this substance, these cells regain their initial rapacities of recognition and inhibition and therefore no longer develop without limitation.
The advantages of this composition are numerous, and in particular in the agricultural sector, farms of all animal species can benefit from it in order to improve their performance: productivity, fertility, birth rate, etc., while also improving the longevity of the animals.

Claims (3)

R E V E N D I C A T I O N S *****************************R E V E N D I C A T I O N S ***************************** 1) Composition régénératrice de cellules caractérisée en ce qu'elle possède la formulation suivante 1) Regenerative composition of cells characterized in that it has the following formulation - 40% Diméthylsulfoxyde - 40% Dimethyl sulfoxide - 20% Sérum isotonique + oligo-éléments - 20% Isotonic serum + trace elements - 40% Anesthésique local - 40% Local anesthetic 2) Application de la. composition selon la revendication 1, en tant que principe actif antitumoral. 2) Application of the. composition according to claim 1, as an anti-tumor active ingredient. 3) Application de la composition selon la revendication 1, à l'élevage de toutes espèces animales en vue de l'amélioration des performances au niveau de la production, de la fertilité, de la natalité, etc.  3) Application of the composition according to claim 1, to the breeding of all animal species with a view to improving performance in terms of production, fertility, birth rate, etc.
FR9304920A 1993-04-22 1993-04-22 Cell regenerating composition and its application in medical, veterinary and agricultural environments. Expired - Lifetime FR2704147B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9304920A FR2704147B1 (en) 1993-04-22 1993-04-22 Cell regenerating composition and its application in medical, veterinary and agricultural environments.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9304920A FR2704147B1 (en) 1993-04-22 1993-04-22 Cell regenerating composition and its application in medical, veterinary and agricultural environments.

Publications (2)

Publication Number Publication Date
FR2704147A1 true FR2704147A1 (en) 1994-10-28
FR2704147B1 FR2704147B1 (en) 1995-07-21

Family

ID=9446459

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9304920A Expired - Lifetime FR2704147B1 (en) 1993-04-22 1993-04-22 Cell regenerating composition and its application in medical, veterinary and agricultural environments.

Country Status (1)

Country Link
FR (1) FR2704147B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001771A1 (en) * 1997-02-15 2000-05-24 Edelstam Inc. A medicament against infertility and for increasing fertility

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3274M (en) * 1964-03-10 1965-04-26 Pluripharm Sarl New medicinal compositions for external use.
FR4077M (en) * 1964-10-08 1966-05-16
US3711602A (en) * 1970-10-30 1973-01-16 Crown Zellerbach Corp Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso
US4312865A (en) * 1980-07-07 1982-01-26 Szucs Murrill M Medication having penetration through cutaneous surfaces into articular and muscular areas
US4469702A (en) * 1981-06-23 1984-09-04 Schulte Thomas L Analgesic composition and use thereof to ameliorate deep and intractable pain
GB2177919A (en) * 1985-07-09 1987-02-04 Aws Shakir Mustafa Salim Synergistic compositions for treating skin/mucosa
US4851442A (en) * 1986-02-12 1989-07-25 W. Keith R. Watson Lidocaine hydrochloride, citric acid and dimethyl sulfoxide, solution, and formation thereof
EP0471135A2 (en) * 1990-08-14 1992-02-19 Kenneth M. Hallam Compositions, medicaments and methods for the promotion of hair growth
US5122540A (en) * 1986-02-28 1992-06-16 W. Keith R. Watson Method and composition for treating warts and throat soreness with DMSO and citric acid

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3274M (en) * 1964-03-10 1965-04-26 Pluripharm Sarl New medicinal compositions for external use.
FR4077M (en) * 1964-10-08 1966-05-16
US3711602A (en) * 1970-10-30 1973-01-16 Crown Zellerbach Corp Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso
US4312865A (en) * 1980-07-07 1982-01-26 Szucs Murrill M Medication having penetration through cutaneous surfaces into articular and muscular areas
US4469702A (en) * 1981-06-23 1984-09-04 Schulte Thomas L Analgesic composition and use thereof to ameliorate deep and intractable pain
GB2177919A (en) * 1985-07-09 1987-02-04 Aws Shakir Mustafa Salim Synergistic compositions for treating skin/mucosa
US4851442A (en) * 1986-02-12 1989-07-25 W. Keith R. Watson Lidocaine hydrochloride, citric acid and dimethyl sulfoxide, solution, and formation thereof
US5122540A (en) * 1986-02-28 1992-06-16 W. Keith R. Watson Method and composition for treating warts and throat soreness with DMSO and citric acid
EP0471135A2 (en) * 1990-08-14 1992-02-19 Kenneth M. Hallam Compositions, medicaments and methods for the promotion of hair growth

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001771A1 (en) * 1997-02-15 2000-05-24 Edelstam Inc. A medicament against infertility and for increasing fertility
EP1001771A4 (en) * 1997-02-15 2000-09-27 Edelstam Inc A medicament against infertility and for increasing fertility
JP3497513B2 (en) 1997-02-15 2004-02-16 エデルシュタム インコーポレイテッド Drugs to increase fertility for infertility

Also Published As

Publication number Publication date
FR2704147B1 (en) 1995-07-21

Similar Documents

Publication Publication Date Title
KR100321665B1 (en) Chitin beads, chitosan beads, processes for producing these beads, carriers made of these beads and processes for producing microsprodidian spores
US7994138B2 (en) Microbial biosurfactants as agents for controlling pests
Thomas et al. Reduction of feeding by the variegated grasshopper, Zonocerus variegatus, following infection by the fungal pathogen, Metarhizium flavoviride
Yanagawa et al. The role of antennae in removing entomopathogenic fungi from cuticle of the termite, Coptotermes formosanus
DE1945680A1 (en) Enzymatically active adduct and process for its preparation
Pfaender et al. Effect of nutrient additions on the apparent cometabolism of DDT
CN105646752A (en) Fluorescent star polymer, preparation method and applications thereof
CN111685136A (en) Compound insect sex pheromone preparation and preparation method thereof
Su et al. Self-assembled bovine serum albumin nanoparticles as pesticide delivery vectors for controlling trunk-boring pests
Casco et al. Apoptotic cell death in the central nervous system of Bufo arenarum tadpoles induced by cypermethrin
Liang et al. Volatile sex pheromone in the female German cockroach
FR2704147A1 (en) Cell-regenerating composition and its application in the medical, veterinary and agricultural fields
Yurchenko et al. The morphology, biology, and geography of a necrotrophic basidiomycete Athelia arachnoidea in Belarus
Kunesch et al. A fungal metabolite as the male wing gland pheromone of the bumble-bee wax moth, Aphomia sociella L.
FR2504779A1 (en) INSECTICIDE COMPOSITION BASED ON CYPERMETHRIN
CN106632230A (en) Aspergillus unguis bromo-depsidone compound and preparation method and application thereof
CN111892925B (en) Red fluorescent carbon dot and preparation method and application thereof
BE674909A (en)
Falsini et al. Tannins-lignin mixed nanoformulations for improving the potential of neem oil as fungicide agent
Colazza et al. Application of chemical cues in arthropod pest management for orchards and vineyards
KR101822252B1 (en) Trapping agent of monochamus alternatus and method for manufacturing the same and method for controlling bursaphelenchus xylophilus using the same
Willeford et al. Efficacy of phloxine B as a bactericidal agent in plants
EP3295799A1 (en) Antifungal agent, pesticide, method for controlling plant disease by means of microorganism, and novel bacillus subtilis
RU2077203C1 (en) Preparation for struggle against blood-sucking mosquito larvae
RU2028382C1 (en) Yeast strain rhodotorula gracillis - a producer of carotinoids